STAT3 CRISPR knock-out sensitive K562s had reduced cell growth and survival when treated with increasing doses of IM, indicating the importance of STAT3 for CML persistence during IM-treatment (Fig. S2B, C). The gene discussed is STAT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.